medinfo (![[info]](http://l-stat.livejournal.com/img/userinfo.gif){kind=small} medinfo) wrote,@ 2007-10-23 00:47:00 |
|
Should You Buy It? Forest Labs a Bargain
</a>
Street.Com - On Sept. 5, Forest won a key court appeal, blocking Teva Pharmaceutical ( TEVA - Cramer's Take - Stockpickr ) from making a generic version of its antidepressant Lexapro until the patent expires in 2012. The drug generated some $2.1 billion of revenue
Lundbeck partner Forest Labs reports 7 pct sales growth of Lexapro
CNBC - COPENHAGEN (Thomson Financial) - Lundbeck AS's US-based partner, Forest Laboratories Inc, said its second-quarter sales of the Danish pharmaceutical company's Lexapro depression drug increased 7 pct year-on-year to 559 mln usd. Jyske Bank, which had
</a>
Street.Com - On Sept. 5, Forest won a key court appeal, blocking Teva Pharmaceutical ( TEVA - Cramer's Take - Stockpickr ) from making a generic version of its antidepressant Lexapro until the patent expires in 2012. The drug generated some $2.1 billion of revenue
Lundbeck partner Forest Labs reports 7 pct sales growth of Lexapro
CNBC - COPENHAGEN (Thomson Financial) - Lundbeck AS's US-based partner, Forest Laboratories Inc, said its second-quarter sales of the Danish pharmaceutical company's Lexapro depression drug increased 7 pct year-on-year to 559 mln usd. Jyske Bank, which had
